Role and regulation of CXC-chemokines in acute experimental keratitis
Experimental Eye Research, ISSN: 0014-4835, Vol: 76, Issue: 2, Page: 221-231
2003
- 41Citations
- 13Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations41
- Citation Indexes41
- 41
- CrossRef29
- Captures13
- Readers13
- 13
Article Description
The aim of this study was to elucidate the expression of chemokines, their role and regulation in bacterial corneal infection using three bacterial strains ( Pseudomonas. aeruginosa - invasive, cytotoxic and contact lens induced acute red eye strains) which have been shown to produce three distinct patterns of corneal disease in the mouse. The predominant chemokine expressed in response to all three strains was MIP-2. Prolonged expression of high levels of MIP-2 was associated with increased severity of corneal inflammation. Significantly reduced disease severity upon administration of anti-MIP-2 antibodies suggested that MIP-2 may play an important role in the pathogenesis of Pseudomonas keratitis at least in part by being a major chemoattractant for polymorphonuclear leukocytes (PMN) recruitment. Interestingly, the numbers of bacteria in eyes with neutralized MIP-2 activity did not decrease even though the severity of the disease was decreased. This implies PMNs as the major destructive factor in microbial keratitis. Further, neutralization of IL-1β activity alone using monoclonal antibodies resulted in significant reduction of both MIP-2 and KC activity indicating that chemokine levels were regulated by IL-1β. These studies demonstrate that the regulation of MIP-2 activity may be beneficial in reducing corneal damage during microbial keratitis in rodents and perhaps that regulation of the human homologue of MIP-2, IL-8, may be useful for controlling keratitis in humans.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0014483502002701; http://dx.doi.org/10.1016/s0014-4835(02)00270-1; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0037332111&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12565810; https://linkinghub.elsevier.com/retrieve/pii/S0014483502002701; http://linkinghub.elsevier.com/retrieve/pii/S0014483502002701; http://api.elsevier.com/content/article/PII:S0014483502002701?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0014483502002701?httpAccept=text/plain; http://dx.doi.org/10.1016/s0014-4835%2802%2900270-1; https://dx.doi.org/10.1016/s0014-4835%2802%2900270-1
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know